1. Scrip
  2. >>Focus On Asia
  3. >>India

Sun Lays Out Halol Compliance Plan As Results Trounce Forecasts

 
• By Nell MacRae

India’s Sun Pharma has surprised investors with a strong leap in profit and it says it will lodge a request by the end of June with the US FDA to re-inspect its troubled Halol plant, in the first official indication of a likely timeline for the restoration of compliance at the facility.

NEW DELHI - Sun Pharmaceutical Industries Ltd., India’s largest pharma firm, has reported a quarterly profit jump that was more than double analysts' forecasts and cheered investors further by announcing it would ask the US regulatory watchdog to re-inspect its key Halol factory by the end of June.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia